z-logo
open-access-imgOpen Access
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
Author(s) -
Emmanuel B. Walter,
Kawsar R. Talaat,
Charu Sabharwal,
Alejandra Gurtman,
Stephen Lockhart,
Grant Paulsen,
Elizabeth D. Barnett,
Flor M. Muñoz,
Yvonne Maldonado,
Barbara Pahud,
Joseph B. Domachowske,
Eric A. F. Simões,
Uzma Sarwar,
Nicholas Kitchin,
Luke Cunliffe,
Pablo Rojo,
Ernest Kuchar,
Mika Rämet,
Iona Munjal,
John L. Perez,
Robert W. Frenck,
Eleni Lagkadinou,
Kena A. Swanson,
Hua Ma,
Xia Xu,
Kenneth Koury,
Susan Mather,
Todd Belanger,
David Cooper,
Özlem Türeci,
Philip R. Dormitzer,
Uǧur Şahin,
Kathrin U. Jansen,
William C. Gruber
Publication year - 2021
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2116298
Subject(s) - covid-19 , virology , medicine , computer science , outbreak , infectious disease (medical specialty) , disease
Safe, effective vaccines against coronavirus disease 2019 (Covid-19) are urgently needed in children younger than 12 years of age.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom